Quick Answer
Oric Pharmaceuticals, Inc. reported Stockholders Equity of $384.36 million for fiscal year 2025.
Oric Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $384.36M | +58.1% |
| 2024 | $243.12M | +8.5% |
| 2023 | $224.09M | +0.8% |
| 2022 | $222.35M | -18.5% |
| 2021 | $272.98M | -5.8% |
| 2020 | $289.78M | +421.7% |
| 2019 | -$90.08M | -39.8% |
| 2018 | -$64.43M | -47.7% |
| 2017 | -$43.61M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $406.92M | +48.5% | +25.6% |
| June 30, 2025 | $324.00M | +7.1% | +47.4% |
| March 31, 2025 | $219.74M | -33.1% | -9.6% |
| December 31, 2024 | $243.12M | +8.5% | -11.3% |
| September 30, 2024 | $273.99M | +10.7% | -9.4% |
| June 30, 2024 | $302.40M | +12.5% | -8.0% |
| March 31, 2024 | $328.64M | +62.0% | +46.7% |
| December 31, 2023 | $224.09M | +0.8% | -9.4% |
- Oric Pharmaceuticals, Inc. showed an increase of +58.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Oric Pharmaceuticals, Inc.’s stockholders equity has grown by 981.3% (from -$43.61 million to $384.36 million).
- The most recent figure is from Oric Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: